<DOC>
	<DOCNO>NCT01640041</DOCNO>
	<brief_summary>The purpose study test innovative , advance FNS microstimulator technology develop Alfred Mann Foundation ( Santa Clarita , CA ) call , Radio Frequency Microstimulation ( RFM ) Gait System promise provide FNS train restoration functional gait component manner least efficacious current investigational FNS system . The design feature RFM Gait System intend address problem current FNS system . The RFM implant device small enough insert use 5 mm incision [ 3 ] . Because electrode ( anode cathode ) contain within microstimulator , lead wire traverse skin , joint , torso/limb juncture . Individual RFMs insert motor point nerve paretic muscle involve limb coordinate use radio frequency technology .</brief_summary>
	<brief_title>Feasibility Study Enhancing Gait Following Stroke With Implanted Microstimulators</brief_title>
	<detailed_description>The primary objective ( Aim I ) study evaluate whether RFM Gait System restore capability perform component gait require safe , functional walking , patient chronic phase stroke ( &gt; 12 month ) . We assess treatment provide RFM system Cleveland VA compare FNS percutaneous Schreiner electrodes custom-designed controller previously investigate investigator . The similarity RFM-based percutaneous FNS system assess use six gait component require execution functional , safe gait , low limb strength , coordination , index walk endurance , muscle tone , walk speed , quality life . The secondary objective study test technological performance safety RFM Gait System . Measures technology performance safety include implantation time ; anchor capability motor point muscle ; reliability RFMs use ; reliability electrical performance system ; comfort system ( stimulation ) ; comfort electrical stimulus .</detailed_description>
	<mesh_term>Paresis</mesh_term>
	<criteria>1 . Cognition intact give valid inform consent participate . 2 . Sufficient endurance participate rehabilitation session . 3 . Ability follow 2 stage command , English . 4 . Medically stable . 5 . Age &gt; 21 year . 6 . Impaired ambulation follow : inability flex knee ankle sagittal plane , normal manner foot clear floor , inability control normal knee angle single limb weight bear stance phase . 7 . Minimum trace ( Manual Muscle Test score 1 ) contraction hip , knee , ankle flexor extensor volitional control . 8 . Passive range motion hip , knee , ankle normal gait kinematics . 9 . Five degree ( 5° ) motion knee ankle flexor extensor produce muscle stimulation achieve noninvasively electrical stimulation apply skin surface . 10 . At least 12 month post stroke . 11 . Ability understand inform consent form English . 12 . Thigh low leg circumference length ≤ 50th percentile standard U.S. population morphology measure . * 13 . Participants able walk keep balance without physical assistance 14 . Response Surface Stimulation trace tibialis anterior peronous longus . 15 . Subject unilateral defect 1 . Acute progressive cardiac , renal , respiratory , neurological disorder malignancy . 2 . Active psychiatric diagnosis psychological condition , active drug/alcohol abuse . 3 . Lower motor neuron damage radiculopathy . 4 . More one stroke . 5 . Allergy contraindication anesthesia , Versed , ( comparable substitute ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>